药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Prulifloxacin.
Flurandrenolide
CUDC-907
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with CUDC-907.
Flurandrenolide
Anisodamine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Anisodamine.
Flurandrenolide
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pazufloxacin.
Flurandrenolide
Ebastine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ebastine.
Flurandrenolide
Rupatadine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Rupatadine.
Flurandrenolide
Bilastine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bilastine.
Flurandrenolide
Difloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Difloxacin.
Flurandrenolide
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Sarafloxacin.
Flurandrenolide
Phosmet
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Phosmet.
Flurandrenolide
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Orbifloxacin.
Flurandrenolide
Famphur
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Famphur.
Flurandrenolide
Acrivastine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Acrivastine.
Flurandrenolide
Niguldipine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Niguldipine.
Flurandrenolide
Lacidipine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lacidipine.
Flurandrenolide
Efonidipine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Efonidipine.
Flurandrenolide
Aranidipine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Aranidipine.
Flurandrenolide
Pinaverium
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pinaverium.
Flurandrenolide
Vilanterol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vilanterol.
Flurandrenolide
Olodaterol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Olodaterol.